Abstract
A series of coumarin and aza-coumarin derivatives (II–IX) were synthesized and identified using IR, 1H NMR, and 13C NMR spectral data. All the synthesized compounds were assessed for their in vitro antiproliferative activity against Hepatocellular carcinoma (HepG2 cell line), and breast cancer (MCF-7 cell line). In vitro results showed that compounds (III) and (IX) were the most effective compounds against MCF-7 cell line and compound (IV) was the most effective compound against HepG2. Further in vitro study of compounds (III and IX). Compound (III) arrested cell cycle at G2/M phase and induction of apoptosis at pre-G1 phase while compound (IX) arrested cell cycle at G1/S phase. The most potent compounds (III and IX) showed good inhibitory activity against topoisomerase II enzyme. Also, compounds (III and IX) have induced apoptosis at the early and late apoptotic levels.
Similar content being viewed by others
REFERENCES
Mourad, A.A.E., Rizzk, Y.W., Zaki, I., Mohammed, F.Z., and El Behery, M., J. Mol. Struct., 2021, vol. 1242, p. 130722. https://doi.org/10.1016/j.molstruc.2021.130722
Rashid, M., Husain, A., and Mishra, R., Eur. J. Med. Chem., 2012, vol. 54, pp. 855–866. https://doi.org/10.1016/j.ejmech.2012.04.027
Bawa, S., Kumar, S., Drabu, S., and Kumar, R., J. Pharm. Bioallied Sci., 2010, vol. 2, pp. 64–71. https://doi.org/10.4103/0975-7406.67002
Grover, J. and Jachak, S.M., RSC Adv., 2015, vol. 5, pp. 38892–38905. https://doi.org/10.1039/C5RA05643H
Al-Majedy, Y., Kadhum, A., Ibraheem, H., Al-Amiery, A., Moneim, A. A., and Mohamad, A. B., Syst. Rev. Pharm., 2018, vol. 9, pp. 49–54. https://doi.org/10.5530/srp.2018.1.10
Hassan, M.Z., Osman, H., Ali, M.A., and Ahsan, M.J., Eur. J. Med. Chem., 2016, https://pubmed.ncbi.nlm.nih.gov/27484512/. https://doi.org/10.1016/j.ejmech.2016.07.056. Accessed October 15, 2020.
Pinto, D.C.G.A. and Silva, A.M.S., Curr. Top. Med. Chem., 2017, vol. 17, pp. 3190 –3198. https://doi.org/10.2174/1568026618666171215095750
Marshall, M. E., Butler, K., and Fried, A., Mol. Biother., 1991, vol. 3, pp. 170–178.
Jiménez-Orozco, F.A., Molina-Guarneros, J.A., Mendoza-Patiño, N., León-Cedeño, F., Flores-Pérez, B., Santos-Santos, E., and Mandoki, J.J., Melanoma Res., 1999, vol. 9, pp. 243–247. https://doi.org/10.1097/00008390-199906000-00005
Kolodziej, H., Kayser, O., Woerdenbag, H.J., van Uden, W., and Pras, N., J. Naturforsch., C: J. Biosci., 1997, vol. 52, pp. 240–244. https://doi.org/10.1515/znc-1997-3-416
Fylaktakidou, K.C., Hadjipavlou-Litina, D.J., Litinas, K.E., and Nicolaides, D.N., Curr. Pharm. Des., 2004, vol. 10, pp. 3813–3833. https://doi.org/10.2174/1381612043382710
Liang, S.-C., Ge, G.-B., Liu, H.-X., Zhang, Y.-Y., Wang, L.-M., Zhang, J.-W., Yin, L., Li, W., Fang, Z.-Z., Wu, J.-J., Li, G.-H., and Yang, L., Drug Metab. Dispos., 2010, vol. 38, pp. 973–980. https://doi.org/10.1124/dmd.109.030734
Finn, G.J., Creaven, B.S., and Egan, D.A., Biochem. Pharmacol., 2004, vol. 67, pp. 1779–1788. https://doi.org/10.1016/j.bcp.2004.01.014
Finn, G.J., Creaven, B., and Egan, D.A., Melanoma Res., 2001, vol. 11, pp. 461–467. https://doi.org/10.1097/00008390-200110000-00004
Finn, G.J., Kenealy, E., Creaven, B.S., and Egan, D.A., Cancer Lett., 2002, vol. 183, pp. 61–68. https://doi.org/10.1016/s0304-3835(02)00102-7
Kostova, I., Curr. Med. Chem.: Anti-Cancer Agent., 2005, vol. 5, pp. 29–46. https://doi.org/10.2174/1568011053352550
Jain, S., Chandra, V., Kumar Jain, P., Pathak, K., Pathak, D., and Vaidya, A., Arab. J. Chem., 2019, vol. 12, pp. 4920–4946. https://doi.org/10.1016/j.arabjc.2016.10.009
Ryckebusch, A., Garcin, D., Lansiaux, A., Goossens, J.-F., Baldeyrou, B., Houssin, R., Bailly, C., and Hénichart, J.-P., J. Med. Chem., 2008, vol. 51, pp. 3617–3629. https://doi.org/10.1021/jm800017u
El-Deen, I., and Abd El-Fattah, M. E., Indian J. Heterocycl. Chem., 1999, vol. 8, pp. 319–324.
Rizzk, Y.W., El-Deen, I.M., Mohammed, F.Z., Abdelhamid, M.S., and Khedr, A.I.M., Anticancer Agents Med. Chem., 2020, vol. 19, pp. 2010–2018. https://doi.org/10.2174/1871520619666190930143856
Zaki, I., El-Sayed, E.-S.H., and Radwan, E.M., Russ. J. Bioorg. Chem., 2021, vol. 47, pp. 514–523. https://doi.org/10.1134/S106816202102028X
Lakhani, S.A., Masud, A., Kuida, K., Porter, G.A., Booth, C.J., Mehal, W.Z., Inayat, I., and Flavell, R.A., Science., 2006, vol. 311, pp. 847–851. https://doi.org/10.1126/science.1115035
Han, J., Talorete, T.P.N., Yamada, P., and Isoda, H., Cytotechnology, 2009, vol. 59, pp. 45–53. https://doi.org/10.1007/s10616-009-9191-2
Abdelhameid, M.K., Zaki, I., Mohammed, M.R., and Mohamed, K.O., Bioorg. Chem., 2020, vol. 101, p. 103995. https://doi.org/10.1016/j.bioorg.2020.103995
Mourad, A.A.E., Rizzk, Y.W., Zaki, I., Mohammed, F Z., and El Behery, M., J. Mol. Struct., 2021, vol. 1242, pp. 130722.
Topcu, Z., J. Clin. Pharm. Ther., 2001, vol. 26, pp. 405–416. https://doi.org/10.1046/j.1365-2710.2001.00368.x
Zaki, I., Abdelhameid, M.K., El-Deen, I.M., Abdel Wahab, A.H.A., Ashmawy, A.M., and Mohamed, K.O., Eur. J. Med. Chem., 2018, vol. 156, pp. 563–579. https://doi.org/10.1016/j.ejmech.2018.07.003
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any studies involving animals or human participants performed by any of the authors.
Conflict of Interests
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Ibrahim M. El-Deen, El-Zend, M.A., Tantawy, M.A. et al. Synthesis and Cytotoxicity Screening of Some Synthesized Coumarin and Aza-Coumarin Derivatives as Anticancer Agents. Russ J Bioorg Chem 48, 380–390 (2022). https://doi.org/10.1134/S106816202202011X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S106816202202011X